PELLEGATA, NATALIA SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 1.281
AS - Asia 922
EU - Europa 829
SA - Sud America 141
AF - Africa 22
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.199
Nazione #
US - Stati Uniti d'America 1.245
CN - Cina 399
SG - Singapore 217
IE - Irlanda 200
HK - Hong Kong 176
RU - Federazione Russa 135
BR - Brasile 124
IT - Italia 109
DE - Germania 100
FI - Finlandia 79
UA - Ucraina 65
VN - Vietnam 42
GB - Regno Unito 35
SE - Svezia 31
FR - Francia 22
CA - Canada 19
IN - India 17
AT - Austria 11
JP - Giappone 11
MX - Messico 11
TR - Turchia 11
ZA - Sudafrica 10
ES - Italia 9
PL - Polonia 9
PK - Pakistan 8
BE - Belgio 7
BD - Bangladesh 6
IQ - Iraq 5
AR - Argentina 4
NL - Olanda 4
ID - Indonesia 3
KE - Kenya 3
KH - Cambogia 3
LT - Lituania 3
MA - Marocco 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CO - Colombia 2
EC - Ecuador 2
EG - Egitto 2
IS - Islanda 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
LB - Libano 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PF - Polinesia Francese 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.199
Città #
Dublin 197
Chandler 186
Hong Kong 176
Ashburn 132
Dallas 132
Beijing 120
Singapore 93
Boardman 75
Jacksonville 60
Nanjing 57
Helsinki 46
Los Angeles 44
Moscow 33
Redondo Beach 33
Lawrence 32
Princeton 32
Medford 30
Munich 28
Wilmington 28
Falkenstein 26
New York 21
Hebei 19
Milan 19
Jiaxing 18
Nanchang 17
Chicago 16
Shanghai 16
Ho Chi Minh City 15
The Dalles 15
Shenyang 14
São Paulo 14
Changsha 13
Monza 13
Buffalo 12
Hanoi 12
Seattle 12
Florence 11
Pavia 11
Tianjin 11
Santa Clara 10
Tokyo 10
Toronto 10
Ann Arbor 9
Brooklyn 9
Chennai 9
Germering 9
Boston 7
Brussels 7
Montreal 7
Secaucus 7
Warsaw 7
Columbus 6
Denver 6
Guangzhou 6
Istanbul 6
Johannesburg 6
Rio de Janeiro 6
Verona 6
Kolkata 5
Orem 5
Padova 5
Phoenix 5
San Francisco 5
Vienna 5
Caserta 4
Curitiba 4
Falls Church 4
Genoa 4
Hangzhou 4
Newark 4
Alessandria 3
Atlanta 3
Bologna 3
Brasília 3
Cape Town 3
Córdoba 3
Da Nang 3
Houston 3
Jaú 3
Norwalk 3
Nova Iguaçu 3
Phnom Penh 3
Roubaix 3
Santo André 3
Tashkent 3
Turku 3
Washington 3
Ankara 2
Bishkek 2
Biên Hòa 2
Bolzano 2
Cairo 2
Cepagatti 2
Cincinnati 2
Des Moines 2
Dhaka 2
Fairfield 2
Frankfurt am Main 2
Handan 2
Jakarta 2
Totale 2.113
Nome #
Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix 132
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesions 116
K-ras gene mutations: an unfavorable prognostic marker in stage I lung adenocarcinoma 111
Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. 99
Primary retroperitoneal mucinous cystoadenocarcinomas: an immunohistochemical and molecular study 97
K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions 94
Genetic events in sporadic colorectal adenomas; K-ras and p53 heterozygous mutations are not sufficient for malignant progression 86
Loss of heterozygosity and K-ras gene mutations in gastric cancer 83
A 5'-truncated c-myc gene variant not associated with a risk of cancer 83
Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients 77
Base transitions are the most frequent genetic changes at P53 in gastric cancer 77
Study on aneuploidy and p53 mutations in astrocytomas 76
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects 75
The significance of p53 mutations in human cancers 74
Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer 74
Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients 71
Characterization of neuroendocrine tumors in heterozygous mutant MENX rats: A novel model of invasive medullary thyroid carcinoma 70
Adiponectin affects the mechanical responses in strips from the mouse gastric fundus 68
Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment 66
The novel SSTR3 full agonist ITF2984 shows antitumor properties against pancreatic neuroendocrine tumors (Pan-NETs) 64
Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development 64
Gene amplification and proliferative kinetics in relation to prognosis of patients with gastric carcinoma 63
Animal models of MEN1 62
CDKN1B (p27) defects leading to pituitary tumors 62
Angpt2/Tie2 autostimulatory loop controls tumorigenesis 60
Animal models of multiple endocrine neoplasia 58
Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice 56
The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis 52
Editorial: Stem Cells in Endocrine Tumors 50
Obesity and cancer – extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases 49
Animal and Cell Culture Models of PPGLs – Achievements and Limitations 48
Multiple Endocrine Neoplasia Type 4 (MEN 4) 46
Tribbles Genes in Gastric Cancer: A Tumor-Suppressive Role for TRIB2 45
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 43
miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance 43
Multiple Endocrine Neoplasia-Type 4 (MEN4) and Other MEN1-Like Syndromes 42
Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors 41
Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics 40
The norepinephrine transporter as a putative predictive biomarker for PI3K/mTOR inhibition in pheochromocytoma. 40
Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging 38
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas 37
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures 37
An AMP-activated protein kinase–stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice 34
Multiple Endocrine Neoplasia Type 4 33
Early onset acromegaly associated with a novel deletion in CDKN1B 5′UTR region 30
NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations 29
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures 28
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome 26
Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo 25
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma 25
Morphology, Biochemistry, and Pathophysiology of MENX-Related Pheochromocytoma Recapitulate the Clinical Features 24
Systematic mapping of mitochondrial calcium uniporter channel (MCUC)-mediated calcium signaling networks 22
Primary Cell Culture Systems for Human Thyroid Studies 22
SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary 21
Inceptor correlates with markers of prostate cancer progression and modulates insulin/IGF1 signaling and cancer cell migration 21
Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas 19
Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model 19
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study 19
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses 19
Ovarian hyperstimulation from ectopic hypersecretion of follicle stimulating hormone 18
Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity 18
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 18
Simultaneous magnetic resonance imaging of pH, perfusion and renal filtration using hyperpolarized 13C-labelled Z-OMPD 15
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome 13
Totale 3.267
Categoria #
all - tutte 17.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 13 8 13 3 12 12 3
2021/2022156 0 0 10 6 1 7 2 24 8 4 15 79
2022/2023550 44 47 4 31 63 59 2 31 246 3 12 8
2023/2024259 19 50 12 21 20 30 41 31 1 14 11 9
2024/2025879 20 64 9 20 8 83 74 64 212 34 83 208
2025/2026991 153 121 209 172 240 96 0 0 0 0 0 0
Totale 3.267